Certara, Princeton, NJ (J.C.D.); Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics and Children's Mercy Research Institute, Children's Mercy Kansas City, Kansas City, Missouri (J.S.L., J.C.D., A.G., V.S.S., R.E.P.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (B.P.)
Certara, Princeton, NJ (J.C.D.); Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics and Children's Mercy Research Institute, Children's Mercy Kansas City, Kansas City, Missouri (J.S.L., J.C.D., A.G., V.S.S., R.E.P.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (B.P.).
Drug Metab Dispos. 2022 Jan;50(1):24-32. doi: 10.1124/dmd.121.000623. Epub 2021 Oct 22.
Microsomal protein per gram of liver (MPPGL) is an important scaling factor for bottom-up physiology-based pharmacokinetic modeling and simulation, but data in pediatrics are limited. Therefore, MPPGL was determined in 160 liver samples from pediatric ( = 129) and adult ( = 31) donors obtained from four sources: the University of Maryland Brain and Tissue Bank (UMBTB), tissue retrieval services at the University of Minnesota and University of Pittsburgh, and Sekisui-Xenotech. Tissues were homogenized and subjected to differential centrifugation to prepare microsomes, and cytochrome reductase activities in tissue homogenates and microsomes were used to estimate cytochrome P450 reductase (POR) activity as a marker of microsomal recovery; microsomal POR content was also assessed by quantitative proteomics. MPPGL values varied 5- to 10-fold within various age groups/developmental stages, and tissue source was identified as a contributing factor. Using a "trimmed" dataset comprised of samples ranging from 3 to 18 years of age common to the four sources, POR protein abundance and activity in microsomes and POR activity in homogenates was lower in UMBTB samples (autopsy) compared with other sources (perfused/flash-frozen). Regression analyses revealed that the UMBTB samples were driving an apparent age effect as no effect of age on log-transformed MPPGL values was observed when the UMBTB samples were excluded. We conclude that a mean±SD MPPGL value of 30.4±1.7 mg/g is representative between one month postnatal age and early adulthood. Potential source effects should be considered for studies involving tissue samples from multiple sources with different procurement and processing procedures. SIGNIFICANCE STATEMENT: Microsomal protein per gram of liver (MPPGL) is an important scaling factor for bottom up PBPK modeling and simulation, but data in pediatrics are limited. Although MPPGL varies 5- to 10-fold at a given developmental stage, a value of 30.4 ± 1.7 mg/g (mean ± SD) is representative between one month postnatal age and early adulthood. However, when tissue samples are obtained from multiple sources, different procurement and processing procedures may influence the results and should be taken into consideration.
肝微粒体蛋白每克肝脏(MPPGL)是自下而上基于生理学的药代动力学建模和模拟的重要缩放因子,但儿科数据有限。因此,在从四个来源获得的 160 个儿科(=129)和成人(=31)供体的肝组织样本中确定了 MPPGL:马里兰大学脑和组织银行(UMBTB)、明尼苏达大学和匹兹堡大学的组织检索服务,以及 Sekisui-Xenotech。组织匀浆并进行差速离心以制备微粒体,组织匀浆和微粒体中的细胞色素 还原酶活性用于估计细胞色素 P450 还原酶(POR)活性作为微粒体回收的标志物;还通过定量蛋白质组学评估微粒体 POR 含量。在各个年龄组/发育阶段内,MPPGL 值变化 5-10 倍,并且鉴定出组织来源是一个促成因素。使用来自四个来源的 3 至 18 岁年龄常见的“修剪”数据集,与其他来源(灌注/闪冻)相比,UMBTB 样本(尸检)中微粒体中的 POR 蛋白丰度和活性以及匀浆中的 POR 活性较低。回归分析表明,UMBTB 样本是导致明显年龄效应的原因,因为当排除 UMBTB 样本时,年龄对对数转换的 MPPGL 值没有影响。我们得出的结论是,在从新生儿后一个月到成年早期之间,30.4±1.7mg/g 的平均±SD MPPGL 值是有代表性的。对于涉及来自具有不同获取和处理程序的多个来源的组织样本的研究,应考虑潜在的来源效应。意义声明:肝微粒体蛋白每克肝脏(MPPGL)是自下而上基于生理学的药代动力学建模和模拟的重要缩放因子,但儿科数据有限。尽管在给定的发育阶段 MPPGL 变化 5-10 倍,但在从新生儿后一个月到成年早期之间,30.4±1.7mg/g(平均值±标准差)是有代表性的。然而,当从多个来源获取组织样本时,不同的获取和处理程序可能会影响结果,应该予以考虑。